CEACAM5/CD66e Antibody (C66/1030), PE/Cy5.5, Novus Biologicals™

CEACAM5/CD66e

Monoclonal

PE-Cyanine5.5

PBS with 0.05% Sodium Azide

CEACAM5

Recombinant full-length human CEACAM5/CD66e protein (Uniprot: P06731)

0.1 mL

Primary

This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This monoclonal antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbladder, urachus, salivary gland, ovary, and endocervix.

Store at 4°C in the dark. Do not freeze.

Flow Cytometry

C66/1030

Flow Cytometry

Carcinoembryonic antigen, carcinoembryonic antigen-related cell adhesion molecule 5, CD66e antigen, CEACD66e, DKFZp781M2392, Meconium antigen 100

Mouse

Protein A or G purified

Apoptosis, Cancer, Cellular Markers, Immunology

1048.0

Human

IgG1 κ